Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 09-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Desonide Cream, 0.05%.
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 09-Dec-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Desonide Cream, 0.05%.